Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 21 Jun 2022 |
2 | Reply to Exam Report (MIS-R) | 09 Nov 2022 |
3 | Journal Copy | 12 Jul 2024 |
4 | TM-O(NOTICE OF OPPOSITION) | 17 Jul 2024 |
5 | TM-O(NOTICE OF OPPOSITION) | 24 Jul 2024 |
1 | EXAMINATION REPORT | 14209281 | 12 Oct 2022 | |
2 | Hearing Notice (Show Cause) | 17517264 | 24 Feb 2024 | |
3 | Tribunal Accepted Notice for : 5497120 | 17718073 | 6631358 | 14 Mar 2024 |
4 | Opposition Notice | 18548087 | 6824677 | 22 Jul 2024 |
5 | Opposition Notice | 18591162 | 6837192 | 29 Jul 2024 |
Leupro-q was applied on 21 June 2022.
Trademark application was filed by QUESTUS PHARMA.
Trademark application has been filed under following classes.
5
As per IP India, trademark application is on the following stage:
Opposed.
Listed application Id of Leupro-q is 5497120.
Trademark attorney of the Leupro-q is I Sreenivasa Murthy.
Leupro-q is a WORD as per IP India data.